| Literature DB >> 35128421 |
Julio A Martinez-Rodriguez1, Francisco J Carbajal1, Rocio Martinez-De-Anda1, Alicia Alcantar-Rodriguez1, Alfredo Medrano1.
Abstract
Cryopreservation compromises the capacity of sperm fertilizing due to a series of alterations in the structure and physiology of the sperm. The use of antioxidants, such as melatonin, added to freezing media, may help to reduce sperm cryoinjury. To test the effect of melatonin on Bulldog (Canis lupus familiaris) sperm cryosurvival, spermatozoa were diluted in a standard freezing medium and cooled to 5°C. Then, more freezing medium was added to obtain 200 × 106 cells/mL, and 5% glycerol. Diluted spermatozoa were treated with melatonin (0.0, 0.0005, 0.002, and 0.0035 mol/L), and packaged in 0.25 mL straws, which were further cooled to -5°C before freezing in liquid nitrogen. Thawing was carried out at 70°C for 5 s, and the progressive motility, viability, plasma membrane integrity, acrosome integrity, capacitation status, and plasma membrane fluidity of the spermatozoa (at 37°C) were assessed. Data were analyzed using ANOVA to detect differences between the melatonin doses. There were statistical differences (P < 0.05) in the percentage of sperm having hyper-fluid membranes, intact acrosome, capacitated acrosome-intact, and acrosome-reacted. The values for the high melatonin doses (0.002 and 0.0035 mol/L) were better than for the low melatonin doses (0.0 and 0.0005 mol/L). In conclusion, 0.002 and 0.0035 mol/L of melatonin improved the cryosurvival of sperm from male bulldogs. LAYEntities:
Keywords: Bulldog semen; antioxidants; cryopreservation; melatonin
Mesh:
Substances:
Year: 2020 PMID: 35128421 PMCID: PMC8812447 DOI: 10.1530/RAF-20-0022
Source DB: PubMed Journal: Reprod Fertil ISSN: 2633-8386
Figure 1The special recipient containing saline solution (NaCl 10%, w/v) employed to cool the straws from 5°C to −5°C; each straw (n = 16) was inserted inside one of the plastic cylinders.
Effect of cooling to different target temperatures on English Bulldog sperm cryosurvival. Values are presented as means ± s.e.m.
| Pre-freeze cooling | Progressive motility (%) | Plasma membrane integrity (%) | Capacitation status (CTC patterns) | Acrosome integrity (%) | ||
|---|---|---|---|---|---|---|
| F (%) | B (%) | AR (%) | ||||
| +5°C | 24.9 ± 3.34 | 28.3 ± 2.48 | 17.9 ± 3.50a | 69.9 ± 2.53a | 12.0 ± 1.59 | 58.9 ± 5.56a |
| −5°C | 22.7 ± 3.25 | 33.2 ± 2.67 | 30.8 ± 6.32b | 59.4 ± 4.71b | 10.0 ± 2.15 | 72.8 ± 4.29b |
Different letters in columns indicate significant differences (P < 0.05).
Effect of cooling to different target temperatures and melatonin (MLT) on English Bulldog sperm cryosurvival. Values are presented as means ± s.e.m.
| Pre-freeze cooling/MLT | Progressive motility (%) | Plasma membrane integrity (%) | Capacitation status (CTC patterns) | Acrosome integrity (%) | ||
|---|---|---|---|---|---|---|
| F (%) | B (%) | AR (%) | ||||
| +5°C | ||||||
| 0 | 26.4 ± 8.48 | 24.6 ± 5.86 | 20.7 ± 11.05 | 71.8 ± 9.71 | 7.5 ± 3.88 | 75.5 ± 2.50 |
| 1 | 22.0 ± 7.02 | 35.7 ± 5.15 | 21.8 ± 7.99 | 69.5 ± 5.63 | 8.7 ± 2.40 | 50.3 ± 25.25 |
| 2 | 24.8 ± 6.59 | 21.9 ± 2.38 | 25.3 ± 12.05 | 64.0 ± 7.57 | 9.7 ± 4.28 | 64.7 ± 19.91 |
| −5°C | ||||||
| 0 | 24.8 ± 7.40 | 40.7 ± 4.44 | 43.2 ± 18.39 | 50.8 ± 14.13 | 6.0 ± 4.54 | 88.0 ± 7.00 |
| 1 | 19.0 ± 6.03 | 31.7 ± 4.78 | 49.0 ± 16.00 | 47.3 ± 15.25 | 3.8 ± 0.75 | 82.3 ± 11.75 |
| 2 | 17.5 ± 5.88 | 31.1 ± 6.20 | 42.3 ± 19.75 | 56.3 ± 18.75 | 1.5 ± 1.00 | 82.3 ± 5.33 |
There were no differences between treatments (cooling x melatonin). MLT: 0, 0.0; 1, 0.001; 2, 0.002 mol/L.
Figure 2Hyper-fluid plasma membranes (%) and intact acrosomes (%) for each for each of the treatments of melatonin (MLT). 0, 0.0; 0.5, 0.0005; 2, 0.002; 3.5, 0.0035 mol/L. Values are means ± s.e.m. Different letters within each line indicate significant differences (P < 0.05).
Effect of melatonin (MLT) on English Bulldog sperm cryosurvival. Values are presented as means ± s.e.m.
| MLT | Progressive motility (%) | Plasma membrane integrity (%) | Hyper-fluid plasma membrane (%) | Capacitation status (CTC patterns) | Acrosome integrity (%) | ||
|---|---|---|---|---|---|---|---|
| F (%) | B (%) | AR (%) | |||||
| 0 | 42.7 ± 4.63 | 33.2 ± 3.42 | 66.5 ± 3.20a | 21.9 ± 2.23 | 34.4 ± 2.29a | 45.6 ± 2.88a | 30.6 ± 3.81a |
| 0.5 | 36.5 ± 4.56 | 36.1 ± 3.52 | 61.8 ± 3.84ab | 22.9 ± 1.55 | 40.4 ± 1.83a | 36.8 ± 2.41a | 29.8 ± 2.84a |
| 2.0 | 41.3 ± 4.21 | 42.1 ± 2.81 | 53.4 ± 3.53bc | 21.8 ± 1.24 | 51.3 ± 2.35b | 26.2 ± 2.43b | 44.7 ± 2.43b |
| 3.5 | 45.1 ± 4.15 | 42.4 ± 2.85 | 48.6 ± 3.33c | 21.7 ± 1.65 | 52.9 ± 2.45b | 26.1 ± 2.64b | 55.2 ± 3.16b |
Values are means ± s.e.m. Different letters in columns indicate significant differences (P < 0.05). MLT: 0, 0.0; 0.5, 0.0005; 2, 0.002; 3.5, 0.0035 mol/L.
Sperm cryosurvival from different English Bulldog males regardless MLT treatments. Values are presented as means ± s.e.m.
| Male | Progressive motility (%) | Plasma membrane integrity (%) | Hyper-fluid plasma membrane (%) | Capacitation status (CTC patterns) | Acrosome integrity (%) | ||
|---|---|---|---|---|---|---|---|
| F (%) | B (%) | AR (%) | |||||
| 1 | 61.5 ± 4.12a | 50.2 ± 5.07a | 59.7 ± 5.79 | 21.3 ± 2.18 | 47.8 ± 3.27 | 29.3 ± 4.20 | 36.1 ± 5.44 |
| 2 | 44.5 ± 7.61ab | 44.9 ± 5.61a | 54.1 ± 4.00 | 22.6 ± 1.67 | 45.5 ± 3.96 | 32.8 ± 3.98 | 32.5 ± 4.92 |
| 3 | 36.6 ± 5.55ab | 38.9 ± 4.41ab | 57.7 ± 5.95 | 23.1 ± 3.07 | 48.3 ± 3.21 | 32.5 ± 4.54 | 44.1 ± 3.76 |
| 4 | 33.5 ± 6.04bc | 34.8 ± 3.73ab | 53.3 ± 7.70 | 24.1 ± 2.14 | 46.8 ± 3.48 | 29.0 ± 3.29 | 39.5 ± 5.30 |
| 5 | 47.1 ± 4.86abc | 39.5 ± 3.87ab | 61.0 ± 5.07 | 24.4 ± 2.37 | 46.5 ± 4.22 | 29.1 ± 3.65 | 44.0 ± 5.33 |
| 6 | 35.8 ± 7.04bc | 39.7 ± 2.78ab | 63.6 ± 3.45 | 20.5 ± 3.06 | 36.8 ± 3.35 | 43.7 ± 5.26 | 28.8 ± 5.30 |
| 7 | 45.8 ± 5.31ac | 35.1 ± 3.26ab | 45.3 ± 5.06 | 23.5 ± 2.38 | 43.8 ± 2.97 | 32.7 ± 2.95 | 45.4 ± 6.18 |
| 8 | 26.5 ± 3.63bc | 24.6 ± 4.37b | 66.0 ± 1.91 | 17.2 ± 1.77 | 42.5 ± 5.59 | 40.3 ± 5.22 | 50.1 ± 4.23 |
Different letters in columns indicate significant differences (P < 0.05).
Characteristics of frozen–thawed spermatozoa from eight individual Bulldog males under the effect of melatonin (MLT). Values are presented as means ± s.e.m.
| Dogs/MLT treatment | Progressive motility (%) | Viability (%) | Hyperfluid membranes (%) | Intact acrosomes (%) | Capacitation status (%) | ||
|---|---|---|---|---|---|---|---|
| F | B | AR | |||||
| Male 1 | |||||||
| 0.0 | 68.3 ± 4.4 | 40.0 ± 10.4 | 72.8 ± 4.6 | 19.0 ± 3.2a | 21.3 ± 7.0 | 38.7 ± 9.4 | 40.0 ± 11.6 |
| 0.5 | 61.0 ± 10.7 | 49.0 ± 13.7 | 68.7 ± 10.0 | 22.7 ± 6.7ab | 21.3 ± 4.7 | 44.0 ± 2.3 | 34. 7 ± 3.7 |
| 2.0 | 51.7 ± 10.1 | 56.2 ± 12.6 | 52.5 ± 13.8 | 43.0 ± 5.6bc | 25.7 ± 2.3 | 52.7 ± 4.1 | 15.7 ± 1.2 |
| 3.5 | 65.0 ± 7.6 | 55.5 ± 6.3 | 44.7 ± 12.7 | 59.7 ± 5.1c | 17.0 ± 3.2 | 56.0 ± 5.6 | 27.0 ± 8.5 |
| Male 2 | |||||||
| 0.0 | 39.0 ± 19.3 | 41.5 ± 14.0 | 62.3 ± 6.7 | 19.5 ± 4.0 | 17.3 ± 2.9 | 31.0 ± 2.7a | 51.7 ± 2.2a |
| 0.5 | 38.3 ± 19.8 | 41.5 ± 20.1 | 58.7 ± 13.0 | 23.2 ± 4.5 | 28.0 ± 3.6 | 35.0 ± 2.9a | 37.0 ± 2.5b |
| 2.0 | 49.0 ± 15.4 | 51.8 ± 4.8 | 50.5 ± 5.8 | 41.8 ± 7.1 | 25.3 ± 1.9 | 57.7 ± 2.2b | 20.3 ± 2.3c |
| 3.5 | 51.7 ± 14.3 | 44.8 ± 5.8 | 45.0 ± 3.6 | 45.5 ± 13.8 | 19.7 ± 0.3 | 58.3 ± 2.9b | 22.0 ± 3.1c |
| Male 3 | |||||||
| 0.0 | 42.3 ± 13.8 | 24.2 ± 7.7 | 67.0 ± 11.9 | 31.8 ± 3.2a | 25.7 ± 12.7 | 39.3 ± 5.6a | 50.3 ± 7.5a |
| 0.5 | 27.3 ± 8.2 | 36.8 ± 6.7 | 69.3 ± 12.1 | 34.2 ± 2.8a | 22.7 ± 4.7 | 40.3 ± 5.5a | 37.0 ± 9.1ab |
| 2.0 | 33.3 ± 8.8 | 44.0 ± 8.9 | 49.8 ± 11.1 | 50.8 ± 3.9b | 22.7 ± 3.2 | 54.0 ± 2.1ab | 23.3 ± 4.1b |
| 3.5 | 43.3 ± 15.9 | 50.5 ± 7.3 | 44.7 ± 11.8 | 59.5 ± 3.3b | 21.3 ± 3.2 | 59.3 ± 3.5b | 19.3 ± 0.9b |
| Male 4 | |||||||
| 0.0 | 27.0 ±10.5 | 22.7 ± 8.2 | 52.3 ± 19.5 | 27.8 ± 9.1 | 25.0 ± 7.9 | 39.0 ± 8.0 | 36.0 ± 6.1 |
| 0.5 | 35.3 ± 21.5 | 37.5 ± 7.5 | 52.3 ± 19.2 | 28.7 ± 8.1 | 27.0 ± 4.6 | 41.7 ± 7.3 | 30.7 ± 10.3 |
| 2.0 | 35.0 ±12.6 | 34.0 ± 4.0 | 53.3 ± 19.4 | 48.0 ± 11.0 | 20.0 ± 1.5 | 52.3 ± 3.9 | 27.7 ± 2.9 |
| 3.5 | 36.7 ± 6.7 | 44.8 ± 6.1 | 55.0 ± 12.2 | 53.7 ± 9.4 | 24.3 ± 1.2 | 54.0 ± 6.9 | 21.7 ± 5.8 |
| Male 5 | |||||||
| 0.0 | 48.0 ± 11.1 | 43.8 ± 10.6 | 73.5 ± 4.4 | 36.2 ± 11.3 | 25.7 ± 5.6 | 28.3 ± 4.6a | 46.0 ± 4.2a |
| 0.5 | 38.3 ± 8.8 | 27.2 ± 2.4 | 68.2 ± 3.4 | 32.2 ± 9.2 | 30.3 ± 5.4 | 41.7 ± 4.4ab | 28.0 ± 5.9ab |
| 2.0 | 47.3 ± 13.2 | 39.5 ± 8.5 | 54.8 ± 13.8 | 42.8 ± 7.8 | 17.7 ± 1.5 | 60.0 ± 3.5b | 22.3 ± 2.9b |
| 3.5 | 54.7 ± 8.7 | 47.7 ± 4.3 | 47.5 ± 11.5 | 64.7 ± 6.1 | 24.0 ± 4.6 | 56.0 ± 5.0b | 20.0 ± 5.1b |
| Male 6 | |||||||
| 0.0 | 41.0 ± 18.6 | 39.2 ± 2.7 | 75.8 ± 3.6a | 21.3 ± 10.9 | 19.7 ± 6.8 | 32.0 ± 5.1 | 48.3 ± 11.7 |
| 0.5 | 31.0 ± 9.7 | 47.3 ± 7.4 | 67.2 ± 5.2ab | 21.3 ± 9.1 | 14.7 ± 0.9 | 39.3 ± 4.8 | 47.7 ± 5.0 |
| 2.0 | 43.0 ± 22.1 | 39.7 ± 5.2 | 60.8 ± 5.7ab | 34.0 ± 9.5 | 23.0 ± 7.4 | 39.3 ± 10.1 | 34.3 ± 12.9 |
| 3.5 | 28.0 ± 9.1 | 32.7 ± 5.2 | 50.7 ± 4.5b | 38.3 ± 14.6 | 24.7 ± 8.7 | 36.7 ± 8.8 | 44.3 ± 14.8 |
| Male 7 | |||||||
| 0.0 | 45.0 ± 9.0 | 33.0 ± 2.3 | 60.5 ± 9.8 | 36.0 ± 19.3 | 25.3 ± 5.3 | 37.3 ± 1.3 | 37.3 ± 4.8 |
| 0.5 | 39.3 ± 14.6 | 33.2 ± 1.0 | 41.3 ± 12.1 | 38.5 ± 14.5 | 20.7 ± 4.3 | 45.3 ± 7.4 | 34.0 ± 6.7 |
| 2.0 | 45.7 ± 8.1 | 39.7 ± 6.1 | 41.5 ± 6.0 | 44.5 ± 5.8 | 23.7 ± 3.2 | 43.3 ± 8.8 | 33.0 ± 9.1 |
| 3.5 | 53.3 ± 14.5 | 34.5 ± 13.3 | 38.0 ± 11.3 | 62.7 ± 2.4 | 24.3 ± 7.9 | 49.3 ± 4.7 | 26.3 ± 3.2 |
| Male 8 | |||||||
| 0.0 | 31.0 ± 13.6 | 21.2 ± 14.8 | 67.8 ± 3.1 | 53.2 ± 11.6 | 15.3 ± 3.7 | 29.7 ± 12.9 | 55.0 ± 13.5 |
| 0.5 | 21.7 ± 4.4 | 16.7 ± 2.2 | 69.0 ± 4.3 | 37.7 ± 7.8 | 18.7 ± 0.9 | 36.0 ± 8.3 | 45.3 ± 7.9 |
| 2.0 | 25.0 ± 5.0 | 31.8 ± 8.4 | 63.5 ± 1.3 | 52.3 ± 4.9 | 16.7 ± 3.8 | 50.7 ± 10.4 | 32.7 ± 9.6 |
| 3.5 | 28.3 ± 6.0 | 28.8 ± 7.4 | 63.5 ± 6.2 | 57.3 ± 7.9 | 18.0 ± 6.0 | 53.7 ± 12.0 | 28.3 ± 6.4 |
Different letters within males indicate significant differences (P < 0.05). MLT: 0, 0.0; 0.5, 0.0005; 2, 0.002; 3.5, 0.0035 mol/L.